South Korean pharma industry sees surge in “overall competitiveness”
CPHI North America to return in hybrid format
Remote audits are on the increase, but more must be done to develop novel excipients
CPhI Report predicts CGT capacity shortages in the USA and mAb approvals in China
CPhI South East Asia rescheduled for November 2020
CPhI 2019 Annual Report: The future of patient-centric CDMOs in the spotlight
CPhI Pharma Awards winners
CPhI Annual Report foresees massive shortfalls in ATP production and bio capacity growth in China
CPhI releases concluding report on trends in biologics
CPhI 2019 Annual report: Technology and regulatory changes in the spotlight
CPhI Worldwide reveals finalists for 2019 Awards
Review: CPhI Korea reports a budding market
CPhI MEA explores the drivers behind the multibillion-dollar market in Saudi Arabia
CPhI Annual Report: Take part in pharma’s largest reputation survey
